Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
The Journal of Trauma and Acute Care Surgery|May 1, 2024
Every minute matters: Improving outcomes for penetrating trauma through prehospital advanced resuscitative careJuan Duchesne, Bryant J McLafferty, Jacob M Broome, et al.
Eclinicalmedicine|August 8, 2024
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extensionAlexander Röth, Catherine M Broome, Wilma Barcellini, et al.
Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.
Diabetologia|February 23, 2008
Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studiesC R Cardwell, L C Stene, G Joner, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 30, 2022
Neuroprotection is improved by watertightness of fetal spina bifida repair in the sheep modelL Joyeux, J van der Merwe, M Aertsen, et al.
The Journal of Trauma and Acute Care Surgery|January 8, 2024
Faster refill in an urban emergency medical services system saves lives: A prospective preliminary evaluation of a prehospital advanced resuscitative care bundleJacob M Broome, Kristen D Nordham, Mark Piehl, et al.
American Journal of Hematology|May 29, 2023
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin diseaseAlexander Röth, Wilma Barcellini, Shirley D'Sa, et al.
Radiation Protection Dosimetry|August 19, 2009
Patient doses in CT examinations in 18 countries: initial results from International Atomic Energy Agency projectsW E Muhogora, N A Ahmed, A Beganovic, et al.
Eclinicalmedicine|August 2, 2024
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part BAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood|June 10, 2022
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trialAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Pageof 23